EMFO LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

EMFO LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-800	Closed	-$66.6K	–	309
2023 Q2	$66.6K	Sell	800 -1,500	-65%	-$125K	0.06%	155
2023 Q1	$175K	Hold	2,300	–	–	0.17%	94
2022 Q4	$191K	Sell	2,300 -1,200	-34%	-$97.2K	0.19%	84
2022 Q3	$278K	Sell	3,500 -300	-8%	-$25.3K	0.26%	79
2022 Q2	$282K	Buy	3,800 +700	+23%	+$52.5K	0.29%	69
2022 Q1	$279K	Buy	+3,100	New	+$286K	0.25%	80

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EMFO LLC's XBI Position: Q3 2023 in Review

EMFO LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 800 shares — an estimated $66.6K sold.

EMFO LLC first reported a position in XBI in Q1 2022 and held it in 6 quarters. The position peaked at $282K in Q2 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

EMFO LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
EMFO LLC sold 800 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $66.6K.
EMFO LLC first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 6 quarters.
EMFO LLC's State Street SPDR S&P Biotech ETF position peaked at $282K in Q2 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on EMFO LLC's 13F filing for Q3 2023, filed 1 Nov 2023.